Linnaeus Therapeutics, Inc. — Form D/A

Linnaeus Therapeutics, Inc. of HADDONFIELD, NJ, a company, filed a Form D amendment with the SEC on 2026-03-31. The offering totals $10.0M, of which $4.9M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-03-31
• Form: D/A
• Accession: 0001752026-26-000006
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $10.0M
• Amount sold: $4.9M
• Remaining: $5.1M
• Minimum investment: $1
• Investors: 26
• Date of first sale: 2026-02-17
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-574940

Issuer

• Name: Linnaeus Therapeutics, Inc.
• CIK: 0001752026
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2015
• Address: 30 WASHINGTON AVENUE, SUITE F, HADDONFIELD, NJ, 08033
• Phone: 856-433-1500

Officers, directors & promoters (25)

Other filings by this issuer (10)

More

• CIK 1752026 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search